TIFFINEY MCMAKIN: Open Payments
NPI 1679116610 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,739 in 139 payments from 32 companies in 2025. Trend: 2023 $1,597 · 2024 $3,534 · 2025 $3,739
Food & beverage: $2,478Long term medical supply or device loan: $1,000Education: $261
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $1,186 |
| AstraZeneca Pharmaceuticals LP | 12 | $341 |
| Janssen Biotech, Inc. | 11 | $282 |
| ABBVIE INC. | 9 | $243 |
| Tempus AI, Inc | 12 | $231 |
| Regeneron Healthcare Solutions, Inc. | 12 | $199 |
| E.R. Squibb & Sons, L.L.C. | 13 | $157 |
| PFIZER INC. | 8 | $122 |
| Genentech USA, Inc. | 1 | $116 |
| Daiichi Sankyo Inc. | 4 | $90 |
Products named: KISQALI, XT CDX, LIBTAYO, Epkinly, IMFINZI, ENHERTU, ERLEADA, Tecentriq.
Industry payments across TX — which companies pay providers there.
